An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Conditions: Non-metastatic Castration-resistant Prostate Cancer; Metastatic Hormone-sensitive Prostate Cancer Interventions: Drug: Darolutamide (Nubeqa, BAY1841788) Sponsors: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials